Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Mucositis during Allogeneic Transplantation Determines Post-Transplant Serum Cyclosporin Levels

Joanne L C Tan, MBBS, Eric Wong, MD, Ashish Bajel, MBBS, FRACP, FRCPA, Radha Ramanan, MBBS, Andrew B M Lim, David Ritchie, MD PhD

Blood (2019) 134 (Supplement_1): 5662.

https://doi.org/10.1182/blood-2019-122363

Published: 2019

Journal Articles

Predictors of Mortality in Neutropenic Enterocolitis Among Children and Young Adults with Acute Myeloid Leukemia in Low Middle Income Countries

Reham Khedr, MD, Mohamed Abdel Waged, Marwa Fathy, MD, Wael Zekri, MD

Blood (2018) 132 (Supplement 1): 5174.

https://doi.org/10.1182/blood-2018-99-114970

Published: 2018

Journal Articles

Beac and BEAM High-Dose Chemotherapy in Patients with Mantle Cell Lymphoma Undergoing Autologous Stem Cell Transplantation Are Efficacious, with Comparable Toxicity

Noa Lavi, MD, Ron Ram, MD, Odelia Amit, MD, Netanel A Horowitz, MD, Tzila Zuckerman, MD

Blood (2016) 128 (22): 5828.

https://doi.org/10.1182/blood.V128.22.5828.5828

Published: 2016

Journal Articles

Mucositis In Patients With Hematologic Malignancies: Prophylaxis Or Treatment - That Is The Question!

Dulcineia Pereira, MD, Sergio Pereira Chacim, MD, Jose Martinez, Edgar Mesquita, MSc, Ines Sousa, MSc, PhD, Angelo Martins, MD, Jose Mario Mariz, MD

Blood (2013) 122 (21): 5618.

https://doi.org/10.1182/blood.V122.21.5618.5618

Published: 2013

Journal Articles

Impact Of Posaconazole Prophylaxis On Invasive Fungal Infection During Acute Myeloid Leukemia Induction Therapy: Correlation With Posaconazole Serum Levels

Chiara Cattaneo, MD, Erika Borlenghi, MD, Annafranca Panzali, Francesca Antoniazzi, MD, Marta Petullà, Francesca Schieppati, MD, Elisa Cerqui, MD, Chiara Pagani, MD, Alessandro Re, MD, Giuseppe Rossi

Blood (2013) 122 (21): 3484.

https://doi.org/10.1182/blood.V122.21.3484.3484

Published: 2013

Journal Articles

Antitumor Efficacy of the Purine-Scaffold Hsp90 Inhibitor PU-H71 in Diffuse Large-B Cell Lymphoma

Eloisi Caldas Lopes, Leandro Cerchietti, Shao Ning Yang, Ari Melnick, Gabriela Chiosis

Blood (2008) 112 (11): 602.

https://doi.org/10.1182/blood.V112.11.602.602

Published: 2008

Journal Articles

Cytoprotective Effect of Palifermin on Gastrointestinal Mucous Membrane Enabled Non-Myeloablative Chemotherapy Administration in ALL Patient with High Risk of Gastrointestinal Toxicity.

Kajetana Foryciarz, MD, Tomasz Sacha, MD PhD, Patrycja Mensah-Glanowska, MD PhD, Agnieszka Balana-Nowak, PhD, Aleksander Skotnicki

Blood (2007) 110 (11): 4332.

https://doi.org/10.1182/blood.V110.11.4332.4332

Published: 2007

Journal Articles

Acute Enterocolitis Incidence in Patients with Hematological Malignancies Receiving Myelotoxic Therapy Requiring Hematopoietic Stem Cell Support - Palifermin Experience.

Isabel Sousa, MD, Catarina Geraldes, MD

Blood (2006) 108 (11): 5461.

https://doi.org/10.1182/blood.V108.11.5461.5461

Published: 2006

Journal Articles

Myeloid Progenitors Protect Against Radiation-Induced Intestinal Injury.

Janice (Wes) Brown, MD, Sumana Shashidhar, MS, Aida Habtezion, MD, Stacy M. Burns-Guydish, PhD, Sophia Y. Wang, BS, Jos Domen, PhD, Tim Fong, PhD, Christopher H. Contag, PhD, M. Bishr Omary, MD

Blood (2005) 106 (11): 5225.

https://doi.org/10.1182/blood.V106.11.5225.5225

Published: 2005

Journal Articles

The Conventional Body Surface Area (BSA) Method of Calculating the Dose of Melphalan (MEL) Results in Widely Variable MEL Exposure and Mucositis Risk in Myeloma (MM) Patients Undergoing Autologous Stem Cell Transplantation (ASCT).

Elias J. Anaissie, MD, Monica L. Grazziutti, MD, Dong Li, MD, MS, Marisa H. Miceli, MD, Athanasios Fassas, MD, Raymond Thertulien, MD, PhD, Sabitha Rajan, Fariba Saghafifar, MD, Guido J. Tricot, MD, Bart Barlogie, MD

Blood (2004) 104 (11): 1159.

https://doi.org/10.1182/blood.V104.11.1159.1159

Published: 2004

NARROW

Mucositis during Allogeneic Transplantation Determines Post-Transplant Serum Cyclosporin Levels

Predictors of Mortality in Neutropenic Enterocolitis Among Children and Young Adults with Acute Myeloid Leukemia in Low Middle Income Countries

Beac and BEAM High-Dose Chemotherapy in Patients with Mantle Cell Lymphoma Undergoing Autologous Stem Cell Transplantation Are Efficacious, with Comparable Toxicity

Mucositis In Patients With Hematologic Malignancies: Prophylaxis Or Treatment - That Is The Question!

Impact Of Posaconazole Prophylaxis On Invasive Fungal Infection During Acute Myeloid Leukemia Induction Therapy: Correlation With Posaconazole Serum Levels

Antitumor Efficacy of the Purine-Scaffold Hsp90 Inhibitor PU-H71 in Diffuse Large-B Cell Lymphoma

Cytoprotective Effect of Palifermin on Gastrointestinal Mucous Membrane Enabled Non-Myeloablative Chemotherapy Administration in ALL Patient with High Risk of Gastrointestinal Toxicity.

Acute Enterocolitis Incidence in Patients with Hematological Malignancies Receiving Myelotoxic Therapy Requiring Hematopoietic Stem Cell Support - Palifermin Experience.

Myeloid Progenitors Protect Against Radiation-Induced Intestinal Injury.

The Conventional Body Surface Area (BSA) Method of Calculating the Dose of Melphalan (MEL) Results in Widely Variable MEL Exposure and Mucositis Risk in Myeloma (MM) Patients Undergoing Autologous Stem Cell Transplantation (ASCT).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only